Literature DB >> 15501252

Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems.

Stefan Gafner1, Sang-Kook Lee, Muriel Cuendet, Sophie Barthélémy, Laurent Vergnes, Serge Labidalle, Rajendra G Mehta, Charles W Boone, John M Pezzuto.   

Abstract

Curcumin is a natural product widely used as a spice in food. It has been shown to inhibit cyclooxygenase (COX)-1 and -2 and to suppress lipopolysaccharide-induced COX-2 and iNOS gene expression. In the present study, curcumin and 22 of its derivatives were evaluated for their chemopreventive potential. Based on COX-2 inhibition, curcumin (IC50=15.9 microM), 1,7-bis(3-fluoro-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione (19) (IC50=23.7 microM) and 2,6-bis(3-fluoro-4-hydroxybenzylidene)cyclohexanone (23) (IC50=5.5 microM) were found to be most potent. Tricyclic derivatives 2,6-bis(4-hydroxy-3-methoxybenzylidene)cyclohexanone (10), 2,6-bis(4-hydroxy-3,5-dimethoxybenzylidene)cyclohexanone (13) and 2,5-bis(4-hydroxy-3,5-dimethoxybenzylidene)cyclopentanone (21) inhibited LPS-induced COX-2 and iNOS gene expression in murine macrophages with potency equal to curcumin. RT-PCR experiments demonstrated suppression of COX-2 and iNOS gene expression occurred at the transcriptional level. The most active compounds in the macrophage assays, 13 and 23, were also the most cytotoxic, however. Topical application of curcumin, 10, 13, 21, and 6, a methoxy derivative of curcumin, showed strong inhibition of 12-O-tetradecanoyl-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity in mouse skin. These data suggest that structural elements responsible for COX-1 and COX-2 inhibition do not correlate well with those responsible for inhibiting COX-2 and iNOS gene expression, but elements capable of inhibiting COX-2 and iNOS gene expression also contribute to inhibition of TPA-induced ODC activity. The most potent compounds in these assays, 10, 13 and 21, as well as curcumin, were further evaluated for inhibition of 7,12-dimethylbenz(a)anthracene (DMBA)-induced preneoplastic lesion formation in a mouse mammary organ culture model, and dose-dependent responses were observed. Most potent effects were at concentrations between 1 and 5 microM for 10, 13 and 21, and at 10 microM for curcumin. These data demonstrate the substitution pattern on the aromatic moiety is especially crucial for activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501252     DOI: 10.1016/j.phytochem.2004.08.008

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  19 in total

1.  Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats.

Authors:  Ilan Aroch; Sarah Kraus; Inna Naumov; Ehud Ron; Shiran Shapira; Dina Kazanov; Nis Giladi; Alex Litvak; Shahar Lev-Ari; Aharon Hallak; Iris Dotan; Baruch Shpitz; Nadir Arber
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

2.  Design, synthesis and experimental validation of novel potential chemopreventive agents using random forest and support vector machine binary classifiers.

Authors:  Brienne Sprague; Qian Shi; Marlene T Kim; Liying Zhang; Alexander Sedykh; Eiichiro Ichiishi; Harukuni Tokuda; Kuo-Hsiung Lee; Hao Zhu
Journal:  J Comput Aided Mol Des       Date:  2014-05-20       Impact factor: 3.686

Review 3.  Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.

Authors:  Subhash Padhye; Deepak Chavan; Shubhangini Pandey; Jyoti Deshpande; K Venkateswara Swamy; Fazlul H Sarkar
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

4.  The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites.

Authors:  Rebecca L Edwards; Paula B Luis; Paolo V Varuzza; Akil I Joseph; Sai Han Presley; Rupesh Chaturvedi; Claus Schneider
Journal:  J Biol Chem       Date:  2017-11-02       Impact factor: 5.157

5.  Analysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography--tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolites.

Authors:  Constantin Tamvakopoulos; Zacharias D Sofianos; Spiros D Garbis; Panayotis Pantazis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

6.  BF3·OEt2-Promoted Concise Synthesis of Difluoroboron-Derivatized Curcumins from Aldehydes and 2,4-Pentanedione.

Authors:  Kai Liu; Jiangmin Chen; Jeremy Chojnacki; Shijun Zhang
Journal:  Tetrahedron Lett       Date:  2013-02-13       Impact factor: 2.415

7.  Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A.

Authors:  Atieh Hajirahimkhan; Charlotte Simmler; Huali Dong; Daniel D Lantvit; Guannan Li; Shao-Nong Chen; Dejan Nikolić; Guido F Pauli; Richard B van Breemen; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2015-11-05       Impact factor: 3.739

8.  Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine.

Authors:  Birgit Waltenberger; Daniela Schuster; Sompol Paramapojn; Wandee Gritsanapan; Gerhard Wolber; Judith M Rollinger; Hermann Stuppner
Journal:  Phytomedicine       Date:  2010-09-20       Impact factor: 5.340

9.  BDMC33, A curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways.

Authors:  Ka-Heng Lee; Yuh-Lit Chow; Vidyadaran Sharmili; Faridah Abas; Noorjahan Banu Mohamed Alitheen; Khozirah Shaari; Daud Ahmad Israf; Nordin Haji Lajis; Ahmad Syahida
Journal:  Int J Mol Sci       Date:  2012-03-06       Impact factor: 6.208

10.  Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.

Authors:  Teresa Kaserer; Veronika Temml; Zsofia Kutil; Tomas Vanek; Premysl Landa; Daniela Schuster
Journal:  Eur J Med Chem       Date:  2015-04-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.